A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals
- 18 May 2015
- Vol. 65 (9), 1505-1513
- https://doi.org/10.1136/gutjnl-2014-308008
Abstract
Objective Endoscopic ultrasonography (EUS) and MRI are promising tests to detect precursors and early-stage pancreatic ductal adenocarcinoma (PDAC) in high-risk individuals (HRIs). It is unclear which screening technique is to be preferred. We aimed to compare the efficacy of EUS and MRI in their ability to detect clinically relevant lesions in HRI. Design Multicentre prospective study. The results of 139 asymptomatic HRI (>10-fold increased risk) undergoing first-time screening by EUS and MRI are described. Clinically relevant lesions were defined as solid lesions, main duct intraductal papillary mucinous neoplasms and cysts ≥10 mm. Results were compared in a blinded, independent fashion. Results Two solid lesions (mean size 9 mm) and nine cysts ≥10 mm (mean size 17 mm) were detected in nine HRI (6%). Both solid lesions were detected by EUS only and proved to be a stage I PDAC and a multifocal pancreatic intraepithelial neoplasia 2. Of the nine cysts ≥10 mm, six were detected by both imaging techniques and three were detected by MRI only. The agreement between EUS and MRI for the detection of clinically relevant lesions was 55%. Of these clinically relevant lesions detected by both techniques, there was a good agreement for location and size. Conclusions EUS and/or MRI detected clinically relevant pancreatic lesions in 6% of HRI. Both imaging techniques were complementary rather than interchangeable: contrary to EUS, MRI was found to be very sensitive for the detection of cystic lesions of any size; MRI, however, might have some important limitations with regard to the timely detection of solid lesions.Keywords
This publication has 23 references indexed in Scilit:
- Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillanceJournal of Medical Genetics, 2012
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancerGut, 2012
- Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk IndividualsGastroenterology, 2012
- Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer FamiliesThe American Journal of Gastroenterology, 2011
- Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and GeneticsClinical Cancer Research, 2010
- The Yield of First-Time Endoscopic Ultrasonography in Screening Individuals at a High Risk of Developing Pancreatic CancerThe American Journal of Gastroenterology, 2009
- Five years of prospective screening of high-risk individuals from families with familial pancreatic cancerGut, 2009
- Screening for Early Pancreatic Neoplasia in High-Risk Individuals: A Prospective Controlled StudyClinical Gastroenterology and Hepatology, 2006
- Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approachClinical Gastroenterology and Hepatology, 2004
- Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic CancerAnnals of Internal Medicine, 1999